The store will not work correctly when cookies are disabled.
2-(5-Ethyl-1H-[1,2,4]triazol-3-yl)-3-(3-nitro-phenyl)-acrylonitrile
ID: ALA116627
PubChem CID: 11359008
Max Phase: Preclinical
Molecular Formula: C17H11N5O2
Molecular Weight: 317.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N#C/C(=C\c1cccc([N+](=O)[O-])c1)c1n[nH]c(-c2ccccc2)n1
Standard InChI: InChI=1S/C17H11N5O2/c18-11-14(9-12-5-4-8-15(10-12)22(23)24)17-19-16(20-21-17)13-6-2-1-3-7-13/h1-10H,(H,19,20,21)/b14-9+
Standard InChI Key: VZRMUFMZXVTNSJ-NTEUORMPSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
4.1917 -4.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6042 -3.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4292 -3.2125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3792 -3.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 -2.6667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5042 -5.0917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3042 -3.0042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9042 -3.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7792 -2.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0292 -4.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1292 -1.7042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1542 -5.8375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.3250 -5.0167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -3.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2042 -4.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7667 -4.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3750 -3.6625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8917 -2.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0667 -3.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9792 -4.1125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9292 -5.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3167 -5.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3625 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -5.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 2 2 0
6 10 1 0
7 4 1 0
8 3 2 0
9 3 1 0
10 15 1 0
11 9 3 0
12 6 1 0
13 6 2 0
14 8 1 0
15 14 2 0
16 4 1 0
17 18 1 0
18 19 2 0
19 14 1 0
20 16 2 0
21 16 1 0
22 21 2 0
23 20 1 0
24 22 1 0
7 5 1 0
23 24 2 0
10 17 2 0
M CHG 2 6 1 12 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 317.31 | Molecular Weight (Monoisotopic): 317.0913 | AlogP: 3.44 | #Rotatable Bonds: 4 |
Polar Surface Area: 108.50 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.22 | CX Basic pKa: 0.15 | CX LogP: 4.72 | CX LogD: 4.71 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.45 | Np Likeness Score: -1.73 |
References
1. Saczewski F, Reszka P, Gdaniec M, Grünert R, Bednarski PJ.. (2004) Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles., 47 (13): [PMID:15189040] [10.1021/jm0311036] |